Hyperthyroidism: Current concepts and management;Aspects actuels des hyperthyroïdies

Revue du Praticien

Volumn 55, Issue 2, 2005, Pages 149-157

  Wemeau, Jean Louis ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTITHYROID AGENT; BENZYLTHIOURACIL; BETA INTERFERON; CARBIMAZOLE; CORTICOSTEROID; CYTOKINE; IODINE 131; LITHIUM; LITHIUM CARBONATE; PREDNISONE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THYROID HORMONE; THYROTROPIN;

CLINICAL FEATURE; DIAGNOSTIC IMAGING; ECHOGRAPHY; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IATROGENIC DISEASE; PREVALENCE; PROGNOSIS; REVIEW; SYMPTOM; THYROID HORMONE SYNTHESIS; THYROID SCINTISCANNING; THYROID SURGERY; THYROTOXICOSIS; TOXIC GOITER; TREATMENT INDICATION;

ANTITHYROID AGENTS; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; PREVALENCE; THYROIDECTOMY;

EID: 13244279659     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Helfend M. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the U.S. Preventive Services Task Force. Ann Intern Med 2004; 128-41.
2. Friesema EC, Grueters A, Biebermann H et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004; 364: 1435-7.
3. Canaris GJ, Maniwitz NR, Mayor G, Ridgway EC. The Colorado Thyroid Disease Prevalence Study. Arch Intern Med 2000; 160: 526-34.
4. Hollowel JG, Staehling NW, Flanders WD et al. Serum TSH T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Exaination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-99.
5. Vanderpump MP, Tunbridge WM, French JM et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43: 55-68.
6. Laurberg P, Bulow Pederson I, Knudsen N, Ovesen L, Andersen S. Environmental iodine intake affects the type of nonmalignant thyroid disease. Thyroid 2001; 11: 457-69.
7. Won BK, Seong MH, Tae YK et al. Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease. Clin Endocrinol (Oxf) 2004; 60: 719-25.
8. Lazarus JH. Hyperthyroidism. Lancet 1997; 349: 339-43.
9. e édition; 2001: 392-8.
10. Cooper DS. Hyperthyroidism. Lancet 2003; 362: 459-68.
11. nd edition; 2003: 177-98.
12. Wemeau JL. Existe-t-il des marqueurs pronostiques de rémission après antithyroïdiens? Ann Endocrinol (Paris) 1994; 55: 15-23.
13. Romaldinl JH, Bromberg N, Werner RS et al. J Clin Endocrinol Metab 1983; 57: 563-70.
14. Benker G, Reinwein D, Kahaly G et al. Is there a methimazole dose effect on remission rate in Graves' disease? Results of a long-term prospective study. Clin Endocrinol (Oxf) 1998; 49: 451-7.
15. Hashizume K, Ichikawa K, Sakurai A et al. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthroidism. N Engl J Med 1991; 324: 947-53.
16. Maugendre D, Gatel A, Campion L et al. Antithyroid drugs and Graves' disease prospective randomized assessment of long-term treatment. Clin Endocrinol (Oxf) 1999; 50: 127-32.
17. Cho BO, Shong MH, Yi KH et al. Evaluation of basal thyreotropin levels and thyreotropin receptor antibodies activities as prognostic markers for discontinuation of antithroid drugs treatment in patients with Graves' disease. Clin Endocrinol (Oxf) 1992; 36: 585-90.
18. Harper L, Chin L, Daykin J et al. Propylthiouracil and carbimazole associated-antineutrophiol cytoplasmic antibodies (ANCA) in patients with Graves' disease Clin Endocrinol (Oxf) 2004; 60: 671-5.
19. Chin TH, An-Tsz H, Dee P et al. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism. Clin Endocrinol (Oxf) 2004; 60: 676-8.
20. e édition; 2001: 349-52.
21. Bournaud C, Orgiazzi J. Antithyroid agents and embryopathies. Ann Endocrinol (Paris) 2003; 64: 366-9.
22. Velayoudom FL, Nocaudie M, Marchandise X et al. Traitement radio-isotopique des goitres bénins. Presse Med 2005 (à paraître).
23. e édition; 2001: 380-5.
24. e édition; 2001: 576-7.